Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionRFG Advisory, LLC
Latest Disclosed Ownership12,836 shares
Latest Disclosed Value $ 1,788,920
RFG Advisory, LLC ownership in GILD / Gilead Sciences, Inc.

On April 17, 2026 - RFG Advisory, LLC filed a 13F-HR form disclosing ownership of 12,836 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,788,920 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 13,205 shares of Gilead Sciences, Inc.. This represents a change in shares of -2.79% during the quarter.

RFG Advisory, LLC has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F GILEAD SCIENCES COM 375558103 12,836 -369 -2.79 1,789 10.37 0.0329
2026-02-03 2025-12-31 13F GILEAD SCIENCES COM 375558103 13,205 283 2.19 1,621 12.97 0.0305
2025-11-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 12,922 162 1.27 1,434 1.41 0.0297
2025-07-28 2025-06-30 13F GILEAD SCIENCES COM 375558103 12,760 -614 -4.59 1,415 -5.61 0.0332
2025-04-09 2025-03-31 13F GILEAD SCIENCES COM 375558103 13,374 -536 -3.85 1,499 16.67 0.0405
2025-01-21 2024-12-31 13F GILEAD SCIENCES COM 375558103 13,910 581 4.36 1,285 14.95 0.0363
2024-10-17 2024-09-30 13F GILEAD SCIENCES COM 375558103 13,329 1,509 12.77 1,117 37.90 0.0340
2024-07-15 2024-06-30 13F GILEAD SCIENCES COM 375558103 11,820 -10,694 -47.50 811 -50.88 0.0264
2024-04-11 2024-03-31 13F GILEAD SCIENCES COM 375558103 22,514 3,249 16.86 1,649 5.71 0.0561
2024-01-25 2023-12-31 13F GILEAD SCIENCES COM 375558103 19,265 2,219 13.02 1,561 22.16 0.0608
2023-10-16 2023-09-30 13F GILEAD SCIENCES COM 375558103 17,046 -3,732 -17.96 1,277 -20.24 0.0571
2023-08-03 2023-06-30 13F GILEAD SCIENCES COM 375558103 20,778 1,541 8.01 1,601 0.31 0.0711
2023-05-09 2023-03-31 13F GILEAD SCIENCES COM 375558103 19,237 275 1.45 1,596 -0.37 0.0781
2023-02-15 2022-12-31 13F GILEAD SCIENCES COM 375558103 18,962 -274 -1.42 1,602 1.26 0.0809
2022-11-10 2022-09-30 13F GILEAD SCIENCES COM 375558103 19,236 945 5.17 1,582 41.63 0.0900
2022-08-09 2022-06-30 13F GILEAD SCIENCES COM 375558103 18,291 8,403 84.98 1,117 89.97 0.0646
2022-05-11 2022-03-31 13F GILEAD SCIENCES COM 375558103 9,888 -36 -0.36 588 -18.45 0.0375
2022-02-02 2021-12-31 13F GILEAD SCIENCES COM 375558103 9,924 1,172 13.39 721 18.00 0.0495
2021-10-19 2021-09-30 13F GILEAD SCIENCES COM 375558103 8,752 116 1.34 611 2.69 0.0502
2021-07-29 2021-06-30 13F GILEAD SCIENCES COM 375558103 8,636 -31 -0.36 595 6.25 0.0529
2021-04-19 2021-03-31 13F GILEAD SCIENCES COM 375558103 8,667 -1,879 -17.82 560 -15.79 0.0610
2021-02-02 2020-12-31 13F GILEAD SCIENCES COM 375558103 10,546 2,978 39.35 665 39.12 0.0870
2020-10-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 7,568 589 8.44 478 -10.99 0.0671
2020-08-03 2020-06-30 13F GILEAD SCIENCES COM 375558103 6,979 3,409 95.49 537 101.12 0.0835
2020-04-17 2020-03-31 13F GILEAD SCIENCES COM 375558103 3,570 363 11.32 267 28.37 0.0501
2020-01-22 2019-12-31 13F GILEAD SCIENCES COM 375558103 3,207 3,207 208 0.0354
2019-11-13 2019-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,408 -100.00 0 -100.00
2019-08-23 2019-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 3,408 3,408 231 0.0527
2019-04-25 2019-03-31 13F GILEAD SCIENCES COM 375558103 0 -6,443 -100.00 0 -100.00
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 6,443 -1,148 -15.12 403 -31.23 0.0990
2018-11-13 2018-09-30 13F GILEAD SCIENCES COM 375558103 7,591 2,236 41.76 586 54.62 0.1536
2018-07-24 2018-06-30 13F GILEAD SCIENCES COM 375558103 5,355 -372 -6.50 379 -12.27 0.1142
2018-05-10 2018-03-31 13F GILEAD SCIENCES COM 375558103 5,727 -467 -7.54 432 -6.09 0.1605
2018-02-08 2017-12-31 13F GILEAD SCIENCES COM 375558103 6,194 198 3.30 460 -6.31 0.2145
2017-11-02 2017-09-30 13F GILEAD SCIENCES COM 375558103 5,996 273 4.77 491 23.68 0.3031
2017-11-01 2017-06-30 13F/A-2 GILEAD SCIENCES COM 375558103 5,723 56 0.99 397 5.31 0.2733
2017-08-14 2017-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 5,588 -135 387 0.1996
2017-08-07 2017-06-30 13F GILEAD SCIENCES COM 375558103 10,779 5,052 750
2017-11-01 2017-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 5,667 -592 -9.46 377 -21.95 0.2848
2017-05-12 2017-03-31 13F GILEAD SCIENCES COM 375558103 5,727 -873 381
2017-11-01 2016-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 6,259 0 0.00 483 -0.21 0.4604
2017-02-07 2016-12-31 13F GILEAD SCIENCES COM 375558103 6,600 341 510
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 6,259 255 4.25 484 -3.39 0.4428
2016-08-03 2016-06-30 13F GILEAD SCIENCES COM 375558103 6,004 -10 -0.17 501 -9.24 0.4356
2016-05-13 2016-03-31 13F GILEAD SCIENCES COM 375558103 6,014 2,643 78.40 552 61.88 0.4311
2016-02-09 2015-12-31 13F GILEAD SCIENCES COM 375558103 3,371 -4,845 -58.97 341 -57.74 0.2509
2015-11-10 2015-09-30 13F GILEAD SCIENCES COM 375558103 8,216 -1,394 -14.51 807 -28.27 2.5988
2015-08-11 2015-06-30 13F GILEAD SCIENCES COM 375558103 9,610 6,570 216.12 1,125 264.08 0.5079
2015-05-13 2015-03-31 13F GILEAD SCIENCES COM 375558103 3,040 3,040 309 0.2355
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-11-10 2015-09-30 13F GILEAD SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-11 2015-06-30 13F GILEAD SCIENCES COM Call 600 12 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.